Chugai Pharmaceutical Co., Ltd. (4519.T)
Develops medicines for cancer, autoimmune diseases, and other serious illnesses worldwide.
7,069.00+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-3.7%
The outlook
Chugai Pharmaceutical trades near the lower quarter of its 52-week range and below both its 50- and 200-day moving averages, though analysts lean bullish with an average target implying 37% upside from current levels. The stock's valuation sits at 24.7x trailing earnings, with modest daily movement and a neutral overall sentiment score reflecting mixed technical and fundamental signals.
What’s behind the score
Analyst consensusBuy — 1.9 avg of 15 analysts
Price trendBelow its 50- & 200-day averages
52-week range24% of the way from its 52-week low to high
Price targetAvg target +37% vs current price
Analyst price target
~12-month · 15 analysts9,686.67average target+37.0% vs now
Now 7,069.00
Low 8,000.00High 13,300.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$11.63T
52-wk high
10,700.00
52-wk low
5,942.00
50-day avg
7,505.42
200-day avg
8,184.89
Trailing P/E
24.7